Truist Securities analyst Richard Newitter raised the price target on Beta Bionics, Inc. (NASDAQ: BBNX) to $32.00 (from $28.00) while ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE